Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

Publication date: Nov 25, 2019

To evaluate the pharmacokinetics of single doses of edaravone oral suspension in Patients with Amyotrophic Lateral Sclerosis

Concepts Keywords
ALS
Amyotrophic Lateral Sclerosis
Antibiotics
BMI
Cervical Spondylosis
Contraception
Differential Diagnosis
Escorial
Informed Consent
Japanese
Liver
Malignancy
Neuron
Pharmacokinetics
Renal

Semantics

Type Source Name
drug DRUGBANK Edaravone
disease MESH Amyotrophic Lateral Sclerosis
disease MESH diagnosis
disease MESH cervical spondylosis
disease MESH malignancy
disease MESH renal
disease MESH infections
disease MESH Motor Neuron Disease

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *